Quality assessment of an integrated care pathway using telemonitoring in patients with chronic heart failure and COPD

Quality assessment of an integrated care pathway using telemonitoring in patients with chronic heart failure and COPD - IN-TOuCH

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON54683

Enrollment

Registered

2018-02-01

Start date

2018-05-30

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure COPD

Interventions

During a period of 2 years patients receive a personalized set of sensors for monitoring relevant vital signs (e.g. blood pressure, weight, oxygen saturation, energy expenditure and/or temperature).

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with both CHF (HFrEF, HFpEF or HFmrEF) and COPD regardless of aetiology 2. At least one hospital admission during the last year (due to CHF/COPD) 3. Age >= 18 year 4. Able to speak and read the Dutch language 5. Life expectancy > 2.5 years 6. Sufficient digital skills (or caregiver)

Exclusion criteria

Exclusion criteria: The patient does not have internet connection Having a psychological disorder preventing participation

Design outcomes

Primary

Measure	Time frame
The primary endpoint is to investigate whether TM in patients with combined CHF and COPD results in a delayed decline or improved quality of life (EQ-5D), as compared to usual care	—

Secondary

Measure	Time frame
Secondary endpoints are: 1. To investigate whether TM in patients with combined CHF and COPD results in a delayed decline or improved HRQoL (MLHFQ, SGRQ). 2. To investigate whether TM results in improved levels of self-management as compared to usual care (PAM13). 3. To investigate patient satisfaction with TM compared to usual care (PREM) 4. To investigate whether patients are compliant to the TM program. 5. To assess health-care costs of TM compared with usual care.	—

Measure

Time frame

Secondary endpoints are: 1. To investigate whether TM in patients with combined CHF and COPD results in a delayed decline or improved HRQoL (MLHFQ, SGRQ). 2. To investigate whether TM results in improved levels of self-management as compared to usual care (PAM13). 3. To investigate patient satisfaction with TM compared to usual care (PREM) 4. To investigate whether patients are compliant to the TM program. 5. To assess health-care costs of TM compared with usual care.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)